Angiotensin II receptor blocker valsartan enhances glucose-induced insulin secretion
A number of antihypertensive drugs are known to be diabetogenic. This may contribute to less than expected decrease in the incidence of coronary heart disease with reduction in blood pressure with treatment in hypertensive patients. This study was aimed to determine the effects of a member, Valsarta...
Main Authors: | Ayob, Azizi, Hashim, Suhaimi, Azdan, Zulnizam, Abdul Razak, Tariq |
---|---|
Format: | Article |
Language: | English |
Published: |
Islamic World Academy of Sciences
2006
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/399/1/Medical_Journal_of_Islamic_World_Academy_of_Sciences.pdf |
Similar Items
-
Kesan in vitro rilmenidine ke atas rembesan insulin
by: Hashim, Rosnani, et al.
Published: (2003) -
Developing and validating a new comprehensive glucose-insulin pharmacokinetics and pharmacodynamics model
by: Ummu Kulthum, Jamaludin
Published: (2013) -
Effects of des-aspartate-angiotensin I on the actions of angiotensin III in the renal and mesenteric vasculature of normo-and hypertensive rats
by: Mustafa, M.R., et al.
Published: (2004) -
Effects of des-aspartate-angiotensin I on the actions of angiotensin III in the renal and mesenteric vasculature of normo-and hypertensive rats
by: Mustafa, Mohd Rais, et al.
Published: (2004) -
The inhibition of glucose absorption of seed and pericarp extracts of Pithecellobium jiringa on intestinal tissues preparation and their phytochemical profiles
by: Kasmuri, Abdul Razak, et al.
Published: (2010)